10X Genomics Inc Class A (TXG)

R&D Expense Growth

-0.10%

Quarterly · Period ending:

TXG logo

TXG R&D Expense Growth

Latest reported-0.10%
TXG Quarterly R&D Growth (QoQ) (0.00% → -0.10%)
High-resolution chart · PNG

TXG r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-0.0985%
1.5687%
-2.1418%
-6.5824%
-4.7023%
-4.0661%
1.1999%
5.175%
-8.3336%
5.1649%
-39.5166%
51.0062%
6.5009%
5.4768%
-5.4629%
-4.803%
10.3109%
3.5437%
13.3799%
2.2097%
27.5028%
5.4855%
31.7221%
9.4716%
5.9364%
-6.802%
25.5752%
23.1507%
20.5079%
14.4113%
17.9973%
-3.137%
-22.6182%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.